Literature DB >> 938176

Goodpasture syndrome: recovery after severe renal insufficiency.

L H Cohen, C B Wilson, R M Freeman.   

Abstract

A 22-year-old woman developed the sudden onset of cough, dyspnea, blood-tinged sputum, and bilateral fluffy infiltrates on her chest x-ray film, together with severe iron deficiency anemia. Urinalysis initially revealed normal values, but gross hematuria developed on the 12th day. Linear deposits of IgG and C3 were present in the GBM; circulating anti-GBM antibodies were also observed initially but had disappeared 13 months later. Hemodialysis was performed because of oliguria and a rising serum creatinine value. She subsequently had a diuresis; 18 months later, the creatinine clearance was 63 ml/min. The anti-GBM antibody response appears to be transient, lasting only a few months, so that if the patient survives the initial insult, stabilization and even some recovery may ensue. Had this patient undergone immediate nephrectomy as part of her initial therapy, the observed favorable outcome would have been denied.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938176     DOI: 10.1001/archinte.136.7.835

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Plasmapheresis and severe glomerulonephritis.

Authors: 
Journal:  Br Med J       Date:  1979-02-17

2.  Treatment of Goodpasture's disease by plasma exchange and immunosuppression.

Authors:  C P Swainson; J S Robson; S J Urbaniak; A J Keller; A B Kay
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

3.  Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis.

Authors:  Mårten Segelmark; Brian D Phillips; Susan L Hogan; Ronald J Falk; J Charles Jennette
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 4.  Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan.

Authors:  Kouichi Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2008-04-08       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.